Key facts
- Notable investors include Nineteen Twenty-One.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Syntactiq
- ·The full record, as it builds
Funding rounds
No funding rounds for Syntactiq are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Syntactiq
Developer of an artificial intelligence research platform designed to enable secure analysis of sensitive health data within institutional infrastructure. The company's platform offers on-premise and private cloud deployment, artificial intelligence-driven data exploration, automated analysis code generation, literature review tools, and integrated Jupyter workflows, enabling research institutions, pharmaceutical companies, and academic organizations to conduct transparent and auditable health data analysis while maintaining data sovereignty and regulatory compliance.
- Sector
- Business Products and Services (B2B)
- HQ
- Vienna, Austria
- Founded
- 2025
- Employees
- 3
- Website
- syntactiq.ai/
- Ownership
- Privately Held (backing)
Syntactiq doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Syntactiq shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Syntactiq in its N-PORT filings yet. We sweep new filings monthly.